Nb v. District of Columbia
34 F. Supp. 3d 146
D.D.C.2014Background
- Nine D.C. Medicaid recipients sued D.C., the Mayor, and DHCF claiming Medicaid prescription claims were "denied, terminated, reduced, or delayed" at pharmacies without required written notice, hearing rights, or continued coverage pending hearing. Plaintiffs seek declaratory and injunctive relief under 42 U.S.C. § 1983 and federal and D.C. law.
- Many alleged incidents occurred when pharmacies used an electronic claims management (ECM) system (operated by a contractor) that returned rejection codes (e.g., for lack of prior authorization, patient "inactive," or quantity limits), causing patients to pay out-of-pocket, accept substitutes, or delay access.
- D.C. law and federal Medicaid rules permit coverage limits (PDL, prior authorization, quantity limits) and substitution of therapeutically equivalent generics; DHCF contracts with a vendor (Xerox/ACS) to process point-of-sale claims.
- Plaintiffs framed pharmacy rejections as state "denials" triggering the notice/hearing obligations under 42 C.F.R. § 431.206 and constitutional due process; D.C. argued many rejections were non-covered claims or resulted from private actors (doctors/pharmacies), not state action.
- The D.C. Circuit previously reversed dismissal for lack of standing as to one plaintiff; on remand the district court considered remaining 12(b)(6) grounds and granted defendants' motions to dismiss.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether pharmacy rejections constitute a statutory "action" (termination/suspension/reduction of covered services) triggering Medicaid notice/hearing requirements | Pharmacy rejections at point-of-sale (ECM rejection codes) are "denials" of covered services and therefore trigger notice and hearing rights | Rejections often reflect prescriptions that are not "covered" (e.g., lack prior authorization, nonpreferred drugs, quantity limits) or permissible substitutions, so no state "termination, suspension, or reduction" of a covered service occurred | Court: Many alleged rejections did not allege denial of a "covered" service; where non-covered or permissibly substituted, no statutory "denial" occurred and notice/hearing obligations were not triggered |
| Whether alleged deprivations were caused by state action for constitutional due process purposes | ECM processing and DHCF/Xerox responses constitute state action; plaintiffs were deprived of property interest without process | Rejections were caused by private actors (physicians, pharmacists, pharmacy IT errors); private conduct is not state action; DHCF did not itself deny coverage in those instances | Court: Plaintiffs failed to allege state action for many rejections; where deprivations might be alleged, complaint attributes them to private actors and alleges only conclusory state involvement, so no state-action-based due process claim stated |
| Whether Medicaid recipients had a protected property interest in any prescription presented at a pharmacy | Recipients have a property interest in claims for Medicaid benefits and thus a "legitimate claim of entitlement" to challenge denials | Property interest exists only in benefits they are legitimately entitled to under law (i.e., covered drugs meeting regulatory prerequisites such as prior authorization and valid prescription) | Court: Recipients have property interest in Medicaid benefits generally, but not to any and every prescription; claims lacking regulatory prerequisites are not protected entitlements |
| Scope of pendent D.C. law claims after federal claims dismissed | Plaintiffs' D.C. law claims independently support relief | D.C. claims are pendent to federal claims and should be dismissed if federal claims fail | Court: Dismissed D.C. law claims for lack of pendent jurisdiction after federal claims dismissed |
Key Cases Cited
- Frew v. Hawkins, 540 U.S. 431 (recognizes Medicaid as cooperative federal-state program)
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (pleading standard: factual matter must plausibly suggest entitlement to relief)
- Ashcroft v. Iqbal, 556 U.S. 662 (complaints must contain factual content to state plausible claim)
- Pharm. Research & Mfrs. of Am. v. Walsh, 538 U.S. 644 (States have discretion to set Medicaid coverage limits)
- Goldberg v. Kelly, 397 U.S. 254 (welfare recipients entitled to procedural due process protections)
- Bd. of Regents v. Roth, 408 U.S. 564 (property interest and "legitimate claim of entitlement" test)
- Monell v. Dep't of Soc. Servs., 436 U.S. 658 (municipal liability and policy/custom requirement under § 1983)
- Blum v. Yaretsky, 457 U.S. 991 (private medical decisions generally not state action)
- Jackson v. Metro. Edison Co., 419 U.S. 345 (state action requires close nexus between state and challenged private conduct)
- Am. Mfrs. Mut. Ins. Co. v. Sullivan, 526 U.S. 40 (§ 1983 "under color of state law" excludes purely private conduct)